AzTrials
AzTrials

Type 1 Diabetes With a Subcutaneous Insulin PumpDIABRASPORTNCT01277965

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity

A study testing 50%VO2maxTBR50, 50%VO2max TBR80 and 75%VO2max TBR80 in people with Type 1 Diabetes With a Subcutaneous Insulin Pump and Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity, run by Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary aim: To show that in subjects with type 1 diabetes with a subcutaneous continuous insulin infusion, adjustment of the recommended basal insulin flow rate in the event of physical activity allows the subjects to practice sports without any increase in incidence of hypoglycaemia during physical activity or the… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
50%VO2maxTBR50, 50%VO2max TBR80 and 75%VO2max TBR80
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
Mar 2010to Feb 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged over 18 years, presenting type 1 diabetes for at least 1 year
  • Patients on basal-prandial regimen treated with functional insulin therapy
  • Patients with a subcutaneous insulin pump for at least 3 months
  • Patients with HbA1c < 9% less than 3 months before
  • Patients with stable basal flow for at least 1 week
  • Patients able to pedal
  • Patients covered by social security
  • Patients consenting to take part in the study and having signed a written informed consent form.

Who cannot join

  • Patients with a history of severe hypoglycaemia in the 6 months prior to entry into the study
  • Patients unable to detect their hypoglycaemia
  • Patients with perforating foot ulcer or a known history of heart disease or obliterative arteriopathy of the lower limbs, or a history of cerebrovascular accident, or ongoing proliferative retinopathy or renal failure.
  • Patients with poorly controlled hypertension
  • Women either pregnant or likely to become pregnant
  • Patients deprived of liberty by judicial or administrative decision, patients placed under legal guardianship.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, Essonne, 91100

Other trials in France

About this study

Official title: Use of a CMGS to Validate Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Treated With Subcutaneous Continuous Insulin Infusion and Practicing Physical Activity

Primary aim:

To show that in subjects with type 1 diabetes with a subcutaneous continuous insulin infusion, adjustment of the recommended basal insulin flow rate in the event of physical activity allows the subjects to practice sports without any increase in incidence of hypoglycaemia during physical activity or the ensuing hours.

Read more

(NB: hypoglycaemia is defined as blood glucose less than 3 mmol/l or 0,54 g/l in accordance with the EMEA definition).

The proposed algorithms consist of a temporary reduction in basal flow of 50 percent or 80 percent (temporary basal flow TBR50 or TBR80) depending on the intensity of physical activity (50 percent of VO2max or 75 percent of VO2max). Switching off the pump will also be studied as an option to adjust insulin dosage in the event of unprogrammed physical activity (temporary reduction of basal flow by 100 percent).

Secondary aims:

  • Characterisation of hypoglycaemia during and after physical activity based on CGMS data: symptomatic or non-symptomatic nature of hypoglycaemia, time to onset of hypoglycaemia in relation to the start of physical activity, degree and severity of hypoglycaemia.
  • Evaluation of overall variations in blood glucose in the event of physical activity using CGMS data (area under the curve).
  • Evaluation of glucose restoration methods used in the event of hypoglycaemia.
  • Analysis of subgroups of patients with and without hypoglycaemia.
Read the detailed description

Inclusion criteria:

  • Patients aged over 18 years, presenting type 1 diabetes for at least 1 year
  • Patients on basal-prandial regimen treated with functional insulin therapy
  • Patients with a subcutaneous insulin pump for at least 3 months
  • Patients with HbA1c less than 9 percent less than 3 months before
  • Patients with stable basal flow for at least 1 week
  • Patients able to pedal
  • Patients covered by social security
  • Patients consenting to take part in the study and having signed a written informed consent form.

Non-inclusion criteria:

  • Patients with a history of severe hypoglycaemia in the 6 months prior to entry into the study
  • Patients unable to detect their hypoglycaemia
  • Patients with perforating foot ulcer or a known history of heart disease or obliterative arteriopathy of the lower limbs, or a history of cerebrovascular accident, or ongoing proliferative retinopathy or renal failure.
  • Patients with poorly controlled hypertension
  • Women either pregnant or likely to become pregnant
  • Patients deprived of liberty by judicial or administrative decision, patients placed under legal guardianship.

Primary criterion:

Number of episodes of symptomatic or non-symptomatic hypoglycaemia detected by CGMS throughout the duration of physical activity and subsequent hours until the next morning (threshold: 3 mmol/l or 0,54 g/l).

Secondary criteria:

Duration of hypoglycaemia (min), total time in hypoglycaemia (min, percent), time to onset of hypoglycaemia after the start of physical activity, degree (blood glucose level) and severity of hypoglycaemia, area under the algebraic curve during physical activity and in the following hours, nadir of the intervening glucose curve.

Before starting this study, patients will undergo effort testing and measurement of their VO2max in order to precisely define the different thresholds of physical activity.

Tests and proposed insulin adjustment:

  • Tests: Basal period

Each patient will undergo 5 consecutive tests over a 6-month period. The tests will be performed 3 hours after the start of the midday meal in order to define a period during which blood glucose is solely dependent on basal flow. The 5 tests will comprise 4 physical tests and 1 resting test, to be performed in random order:

  • The 4 physical tests will comprise 2 different levels of intensity (50 percent VO2max, 75 percent VO2max). At each of these levels, patients will test 2 insulin dose adjustment algorithms concerning only the basal flow rate of the insulin pump:
  • 50 percent VO2max, TBR reduced by 50 percent (50 percent VO2maxTBR50),
  • 50 percent VO2max, TBR reduced by 80 percent (50 eprcent VO2max TBR80)
  • 75 percent VO2max, TBR reduced by 80 percent (75 percent VO2max TBR80)
  • 75 percent VO2max, pump switched off (75 percent VO2maxTBR100)
  • A resting test will be used as a comparator.

Each physical test will comprise testing on a bicycle ergometer for 40 minutes with:

  • a 5-minute period during which the intensity of physical activity will be raised
  • a 30-minute plateau at the desired intensity and power
  • a 5-minute recovery period. "Prandial" period In the second phase, two further tests at 50 percent VO2max will be performed 90 minutes after the start of the meal in order to evaluate the effect of reducing the rapid-acting insulin bolus at the onset of hypoglycaemia.

At the same time, during the 2 periods ("basal" and "prandial"), patients will be asked to score the intensity of their physical activity on the Borg RPE rating scale.

  • Adjustment of insulin dose:
  • The bolus for the meal preceding physical activity (lunch) will be given as usual, with no deliberate reduction for the ensuing sport.
  • "Basal" period

The adjustments in basal flow proposed at the time of physical activity will take into account the intensity of the ensuing physical activity:

  • moderate physical activity (50 percent VO2max)
  • intense physical activity (75 percent VO2max) with 2 possible options:
  • reduction of basal flow by 50 percent or by 80 percent in the first case
  • reduction of basal flow by 80 percent or switching off the pump in the second case.

In the event of reduced basal flow, this will be maintained throughout the duration of physical activity and for the 2 hours following the end of physical activity. If the pump is switched off, it will remain switched off throughout the entire duration of physical activity, but it will not be removed in order to maintain the study blind. It will be switched on again routinely at the end of the physical activity period, at the same flow rate as that set prior to physical activity.

  • Continuous Monitoring Glucose System (CMGS)

A CMGS to record intervening blood glucose levels will be fitted before lunch and worn until the next morning. Data recorded by the CMGS will not be visible to patients in order to prevent them from attempting to modify their insulin doses based on these values.

Patients will have dinner at 8 o'clock in the evening in their own home in order to allow superimposition of the blood glucose curves and facilitate their interpretation. The CMGS will be removed the next morning after breakfast.

Being tested
50%VO2maxTBR50, 50%VO2max TBR80, 75%VO2max TBR80, 75%VO2max TBR100, Rest
Keywords
Algorithm basal insulin, physical activity, Type 1 diabetes, Insulin pump treatment
Medical subject headings
Motor Activity, Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 50%VO2maxTBR50Other

    The basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (50% VO2max),a temporary basal rate will be reduced by 50%

  • 50%VO2max TBR80Other

    The basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (50% VO2max),a temporary basal rate will be reduced by 80%

  • 75%VO2max TBR80Other

    The basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (75% VO2max),a temporary basal rate will be reduced by 80%

  • 75%VO2max TBR100Other

    Turning off the pump (75%VO2max TBR100).However, in order to maintain the study blindfold, the pump will be switched off but not removed

  • RestOther

    Patient will be in rest, basal insulin flow rate will not be change

Study groups in NCT01277965
Study groupRoleWhat they receive
50% VO2 max, BFR reduced by 50%OtherThe basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (50% VO2max),a temporary basal rate will be reduced by 50%
Receives: Other: 50%VO2maxTBR50
50% VO2 max,BFR reduced by 80%OtherThe basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (50% VO2max),a temporary basal rate will be reduced by 80%
Receives: Other: 50%VO2max TBR80
75% VO2 max, BFR reduced by 80%OtherThe basal rate of the pump will be adjusted in accordance with the intensity of physical activity being performed for moderate physical activity (75% VO2max),a temporary basal rate will be reduced by 80%.
Receives: Other: 75%VO2max TBR80
75% VO2 max, pump switched offOtherTurning off the pump (75%VO2max TBR100).However, in order to maintain the study blindfold, the pump will be switched off but not removed.
Receives: Other: 75%VO2max TBR100
RestOtherPatient will be in rest, basal insulin flow rate will not be change.
Receives: Other: Rest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of episodes of symptomatic or non-symptomatic hypoglycaemia

    Number of episodes of symptomatic or non-symptomatic hypoglycaemia detected by CGMS throughout the duration of physical activity and subsequent hours until the next morning (threshold: 3 mmol/l or 0.54 g/l).

    Measured: 24 hours

Secondary outcomes (1)
  1. Duration of hypoglycaemia

    Duration of hypoglycaemia (min), total time in hypoglycaemia (min, %), time to onset of hypoglycaemia after the start of physical activity, degree (blood glucose level) and severity of hypoglycaemia, area under the algebraic curve during physical activity and in the following hours, nadir of the intervening glucose curve.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2011 (estimated)
  2. Study startMar 2010
  3. Primary completionFeb 2013
  4. Study completionFeb 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01277965
Sponsor's protocol ID
2009 A01136 51
Acronym
DIABRASPORT
Status last verified
Jan 2012
First submitted
14 Jan 2011
Last updated
22 Apr 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing 50%VO2maxTBR50, 50%VO2max TBR80 and 75%VO2max TBR80 in people with Type 1 Diabetes With a Subcutaneous Insulin Pump and Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity, run by Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of episodes of symptomatic or non-symptomatic hypoglycaemia (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in